Holostem Terapie Avanzate has a highly experienced management team, with a sound know-how derived from a long tenure both in business administration and in academic research, successfully applied since many years in translational medicine.
Chairman of the
board of directors
Michele De Luca
Holostem Terapie Avanzate is a university spin-off founded in 2008 through the profitable union among Michele De Luca and Graziella Pellegrini, the University of Modena and Reggio Emilia and Chiesi Farmaceutici S.p.A.
© 2018 Holostem Terapie Avanzate S.r.l.
VAT: 03213240363 -
Payed Up Capital: Euro 700.000,00
Companies Register Office - Modena: 03213240363
Registered with the Administrative Economic Register: MO-368370
Company subject to the management and coordination of Valline s.r.l.
Provide patients suffering from
severe or rare, untreatable diseases
with stem cell-based advanced therapies
through ethical and scientific excellence
FOLLOW US ON
Michele De Luca and Graziella Pellegrini are internationally recognized as leading scientists
in the field of epithelial stem cell biology aimed at clinical application and played a pivotal role in epithelial stem cell-mediated cell therapy
and gene therapy...